Comprehensive analysis of microRNAs in breast cancer
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: MicroRNAs (miRNAs) are short noncoding RNAs (approximately 22 nucleotides in length) that play important roles in breast cancer progression by downregulating gene expression. The detailed mechanisms and biological functions of miRNA molecules in breast carcinogenesis have yet to be fully elucidated. This study used bioinformatics and experimental approaches to conduct detailed analysis of the dysregulated miRNAs, arm selection preferences, 3' end modifications, and position shifts in isoforms of miRNAs (isomiRs) in breast cancer. Methods: Next-generation sequencing (NGS) data on breast cancer was obtained from the NCBI Sequence Read Archive (SRA). The miRNA expression profiles and isomiRs in normal breast and breast tumor tissues were determined by mapping the clean reads back to human miRNAs. Differences in miRNA expression and pre-miRNA 5p/3p arm usage between normal and breast tumor tissues were further investigated using stem-loop reverse transcription and real-time polymerase chain reaction. Results: The analysis identified and confirmed the aberrant expression of 22 miRNAs in breast cancer. Results from pathway enrichment analysis further indicated that the aberrantly expressed miRNAs play important roles in breast carcinogenesis by regulating the mitogen-activated protein kinase (MAPK) signaling pathway. Data also indicated that the position shifts in isomiRs and 3' end modifications were consistent in breast tumor and adjacent normal tissues, and that 5p/3p arm usage of some miRNAs displayed significant preferences in breast cancer. Conclusions: Expression pattern and arm selection of miRNAs are significantly varied in breast cancers through analyzing NGS data and experimental approach. These miRNA candidates have high potential to play critical roles in the progression of breast cancer and could potentially provide as targets for future therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626 · cited 2×
“Previous reports described observing nucleotide additions at the 3’ ends of miRNAs [31,34-36] that could cause mismatches at the terminal of the mapping alignment.”
BackgroundMAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995 · cited 1×
“The MAPK pathways are highly conserved kinase modules involved in fundamental cellular processes such as growth, proliferation, migration, and apoptosis [51].”
BackgroundFast and effective prediction of microRNA/target duplexes
REHMSMEIER, M., STEFFEN, P., HÖCHSMANN, M., & GIEGERICH, R. (2004) · RNA · doi:10.1261/rna.5248604 · Cited by 2,560
MicroRNA-Directed Cleavage of HOXB8 mRNA
Yekta, S., Shih, I.-H., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1097434 · Cited by 1,702
Morin, R. D., O’Connor, M. D., Griffith, M., Kuchenbauer, F., Delaney, A., Prabhu, A.-L., Zhao, Y., McDonald, H., Zeng, T., Hirst, M., et al. (2008) · Genome Research · doi:10.1101/gr.7179508 · Cited by 1,110
NCBI Reference Sequences: current status, policy and new initiatives
Pruitt, K. D., Tatusova, T., Klimke, W., & Maglott, D. R. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn721 · Cited by 736 · cited 1×
“The sequences of mRNAs and other ncRNAs were derived from NCBI RefSeq 47 [38].”
MethodMicroRNAs and their isomiRs function cooperatively to target common biological pathways
Cloonan, N., Wani, S., Xu, Q., Gu, J., Lea, K., Heater, S., Barbacioru, C., Steptoe, A. L., Martin, H. C., Nourbakhsh, E., et al. (2011) · Genome Biology · doi:10.1186/gb-2011-12-12-r126 · Cited by 345 · cited 1×
“Recent studies described a phenomenon in which RNA editing or nucleotide addition generated 3’ end sequence variants of miRNAs [6-13].”
BackgroundDynamic isomiR regulation in Drosophila development
Fernandez-Valverde, S. L., Taft, R. J., & Mattick, J. S. (2010) · RNA · doi:10.1261/rna.2379610 · Cited by 208 · cited 4×
“In order to follow the no-mismatch policy and keep the 3’ end variation, like the method in Fernandez-Valverde’s study [6], we trimmed out the terminal 3’ end mismatch one by one until the perfect match reads were at least 18 nucleotides in length.”
Influential
Cited by
Clinical relevance of circulating cell-free microRNAs in cancer
Schwarzenbach, H., Nishida, N., Calin, G. A., & Pantel, K. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.5 · Cited by 969
Principles and methods of integrative genomic analyses in cancer
Kristensen, V. N., Lingjærde, O. C., Russnes, H. G., Vollan, H. K. M., Frigessi, A., & Børresen-Dale, A.-L. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3721 · Cited by 371
Arm Selection Preference of MicroRNA-193a Varies in Breast Cancer
Tsai, K.-W., Leung, C.-M., Lo, Y.-H., Chen, T.-W., Chan, W.-C., Yu, S.-Y., Tu, Y.-T., Lam, H.-C., Li, S.-C., Ger, L.-P., et al. (2016) · Scientific Reports · doi:10.1038/srep28176 · Cited by 84
Self-citationKUO, W.-T., YU, S.-Y., LI, S.-C., LAM, H.-C., CHANG, H.-T., CHEN, W.-S., YEH, C.-Y., HUNG, S.-F., LIU, T.-C., WU, T., et al. (2016) · Anticancer Research · doi:10.21873/anticanres.11089 · Cited by 55
Self-citationCirculating microRNAs as Promising Tumor Biomarkers
(2014) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2014.09.007 · Cited by 40
Metadata
- Authors
- Chang, H.-T., Li, S.-C., Ho, M.-R., Pan, H.-W., Ger, L.-P., Hu, L.-Y., Yu, S.-Y., Li, W.-H., & Tsai, K.-W.
- Venue
- BMC Genomics
- Published
- 2012-12
- Volume
- 13
- Issue
- S7
- Pages
- S18-S18
- ISSN
- 1471-2164 (ISSN-L)
- OpenAlex
- W2163370258
- Cited by
- 55
- References
- 8
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comprehensive analysis of microRNAs in breast cancer. https://app.cochat.ai/papers/10.1186/1471-2164-13-s7-s18
- The paper
- Chang, H.-T., Li, S.-C., Ho, M.-R., Pan, H.-W., Ger, L.-P., Hu, L.-Y., Yu, S.-Y., Li, W.-H., & Tsai, K.-W. (2012). Comprehensive analysis of microRNAs in breast cancer. BMC Genomics. https://doi.org/10.1186/1471-2164-13-s7-s18
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.